REGENXBIO
RGNX
$16.04
Share price
0.88%
Change (1 day)
-16.28%
Change (1 year)
Categories
EPS for REGENXBIO (RGNX)
EPS in 2023 (TTM): -$6.32
According to REGENXBIO's latest financial reports the company's current EPS (TTM) is -$6.32. In 2022 the company made an earnings per share (EPS) of -$6.50 a decrease over its 2021 EPS that were of $2.94.
EPS history for REGENXBIO from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$6.32 | -2.77% |
| 2022 | -$6.50 | -321.09% |
| 2021 | $2.94 | -198.33% |
| 2020 | -$2.99 | 15.44% |
| 2019 | -$2.59 | -181.19% |
| 2018 | $3.19 | -229.15% |
| 2017 | -$2.47 | 3.35% |
| 2016 | -$2.39 | 5.42% |
| 2015 | -$2.27 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -65.51% | 🇺🇸 USA |